title: ADF/Cofilin-actin rods in neurodegenerative diseases.
abstract: Dephosphorylation (activation) of cofilin, an actin binding protein, is stimulated by initiators of neuronal dysfunction and degeneration including oxidative stress, excitotoxic glutamate, ischemia, and soluble forms of beta-amyloid peptide (Abeta). Hyperactive cofilin forms rod-shaped cofilin-saturated actin filament bundles (rods). Other proteins are recruited to rods but are not necessary for rod formation. Neuronal cytoplasmic rods accumulate within neurites where they disrupt synaptic function and are a likely cause of synaptic loss without neuronal loss, as occurs early in dementias. Different rod-inducing stimuli target distinct neuronal populations within the hippocampus. Rods form rapidly, often in tandem arrays, in response to stress. They accumulate phosphorylated tau that immunostains for epitopes present in "striated neuropil threads," characteristic of tau pathology in Alzheimer disease (AD) brain. Thus, rods might aid in further tau modifications or assembly into paired helical filaments, the major component of neurofibrillary tangles (NFTs). Rods can occlude neurites and block vesicle transport. Some rod-inducing treatments cause an increase in secreted Abeta. Thus rods may mediate the loss of synapses, production of excess Abeta, and formation of NFTs, all of the pathological hallmarks of AD. Cofilin-actin rods also form within the nucleus of heat-shocked neurons and are cleared from cells expressing wild type huntingtin protein but not in cells expressing mutant or silenced huntingtin, suggesting a role for nuclear rods in Huntington disease (HD). As an early event in the neurodegenerative cascade, rod formation is an ideal target for therapeutic intervention that might be useful in treatment of many different neurological diseases.
authors.affiliation: Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, 80523, USA. jbamburg@lamar.colostate.edu
authors.forename: J R
authors.initials: JR
authors.lastname: Bamburg
authors.forename: B W
authors.initials: BW
authors.lastname: Bernstein
authors.forename: R C
authors.initials: RC
authors.lastname: Davis
authors.forename: K C
authors.initials: KC
authors.lastname: Flynn
authors.forename: C
authors.initials: C
authors.lastname: Goldsbury
authors.forename: J R
authors.initials: JR
authors.lastname: Jensen
authors.forename: M T
authors.initials: MT
authors.lastname: Maloney
authors.forename: I T
authors.initials: IT
authors.lastname: Marsden
authors.forename: L S
authors.initials: LS
authors.lastname: Minamide
authors.forename: C W
authors.initials: CW
authors.lastname: Pak
authors.forename: A E
authors.initials: AE
authors.lastname: Shaw
authors.forename: I
authors.initials: I
authors.lastname: Whiteman
authors.forename: O
authors.initials: O
authors.lastname: Wiggan
mesh_terms: D008841:Actin Cytoskeleton / Q000378:metabolism* / Q000473:pathology; D000544:Alzheimer Disease / Q000378:metabolism / Q000473:pathology; D000818:Animals; D051338:Cofilin 1 / Q000378:metabolism*; D006801:Humans; D006816:Huntington Disease / Q000378:metabolism / Q000473:pathology; D002479:Inclusion Bodies / Q000378:metabolism* / Q000473:pathology; D019636:Neurodegenerative Diseases / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D016874:Neurofibrillary Tangles / Q000378:metabolism / Q000473:pathology; D009474:Neurons / Q000378:metabolism* / Q000473:pathology; D018384:Oxidative Stress / Q000502:physiology
chemical_list: D051338:Cofilin 1